Equities

Win-Partners Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3183:TYO

Win-Partners Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,433.00
  • Today's Change-16.00 / -1.10%
  • Shares traded29.70k
  • 1 Year change+7.74%
  • Beta0.3422
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.

  • Revenue in JPY (TTM)87.25bn
  • Net income in JPY2.14bn
  • Incorporated2013
  • Employees630.00
  • Location
    Win-Partners Co Ltd21F, Kyobashi Edogrand, 2-2-1, KyobashiCHUO-KU 104-8306JapanJPN
  • Phone+81 335480790
  • Fax+81 335480791
  • Websitehttps://www.win-partners.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Tissue Engineering Co., Ltd.2.26bn-461.45m23.96bn204.00--4.55--10.61-11.36-11.3655.62129.740.36614.015.6311,071,850.00-7.48-4.87-8.33-5.5159.6259.41-20.43-15.896.59--0.00---2.341.23-278.32--0.5717--
Findex Inc5.90bn1.18bn24.53bn311.0019.874.3116.304.1646.3946.39232.45214.020.94678.734.9918,984,330.0019.2116.4821.5419.1963.7758.1820.2916.354.18--0.0034.7312.516.419.7518.41-4.0213.40
Kusurinomadoguchi Inc11.58bn3.10bn30.04bn484.009.643.156.602.59274.21274.211,023.48838.470.7189--3.1923,926,840.0019.64--34.71--56.56--27.32------0.0872--28.41--133.66------
Mizuho Medy Co Ltd9.67bn2.81bn34.44bn187.0012.252.0411.233.56147.57147.57507.44884.420.49991.172.8851,689,840.0014.5429.3716.0335.7568.7374.8529.0935.778.01--0.0037.844.0012.20-0.032833.97-17.0647.14
Rion Co Ltd27.94bn2.98bn36.45bn1.01k12.211.108.371.30241.73241.732,267.252,682.200.71751.673.8927,692,170.007.656.578.727.6249.5350.1110.669.273.55--0.0028.398.365.377.829.9520.048.61
Nippon Care Supply Co., Ltd.34.10bn2.17bn39.64bn1.45k17.522.114.241.16139.36139.362,194.671,155.761.26101.8030.3523,453,350.008.007.3711.529.8036.4536.776.356.340.7615--0.091359.8011.9410.8813.573.7013.338.76
Cyberdyne Inc4.11bn-3.00m43.98bn211.00--1.7069.7010.71-0.0142-0.014219.46188.520.08331.607.7019,469,190.00-0.1034-1.36-0.1056-1.3861.0857.96-1.24-20.8013.94--0.0108--0.68919.5960.91---5.51--
Win-Partners Co Ltd87.25bn2.14bn44.20bn630.0019.101.7518.320.506675.8575.853,098.48830.261.8321.984.45138,488,200.004.494.298.527.9211.9812.402.452.591.62--0.0068.005.644.759.981.5233.839.52
France Bed Holdings Co Ltd61.19bn2.72bn46.39bn1.81k18.631.135.820.758171.6571.651,627.811,177.550.90172.946.0633,769,870.004.014.195.055.6555.0053.374.454.781.951,504.330.244146.932.382.93-6.0014.15-2.507.39
Medikit Co Ltd23.68bn3.09bn48.12bn989.0014.290.961910.572.03211.98211.981,621.483,149.960.46433.144.1023,940,550.006.075.706.726.3038.5539.3713.0713.845.33--0.000241.813.222.54-1.820.854821.5712.47
Japan Eyewear Holdings Co Ltd17.99bn4.22bn48.17bn580.0011.562.838.042.68172.64172.64736.69704.930.47411.8016.5631,022,410.0011.13--12.75--79.15--23.48--0.785318.060.4966--23.20--80.15------
Nagaileben Co Ltd16.69bn2.48bn56.22bn501.0022.691.4520.403.3780.6280.62544.001,263.590.38981.324.2033,321,640.005.786.906.137.4339.3743.3514.8418.6810.68--0.0067.123.48-0.097-8.81-5.8216.970.00
TAUNS Laboratories Inc14.58bn3.98bn60.01bn316.0015.393.7512.764.1236.6636.66136.75150.350.42710.85793.2746,129,040.0011.65--16.30--65.82--27.28--0.848643.440.557--1.05--9.38------
Kitazato Corp10.98bn3.98bn63.88bn86.0016.033.2915.325.8299.6099.60274.45485.650.57231.838.92--20.77--21.73--66.93--36.29--14.33--0.00--2.20---4.63------
Shofu Inc38.97bn4.25bn64.96bn1.41k15.251.4211.991.67118.98118.981,092.321,279.850.75741.239.8127,577,490.008.287.279.278.2459.4558.4110.949.752.72--0.0032.9910.318.1918.1143.72-3.1930.39
Data as of Feb 13 2026. Currency figures normalised to Win-Partners Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

12.89%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Nov 20252.79m9.14%
Nomura Asset Management Co., Ltd.as of 08 Jan 2026478.30k1.57%
Amova Asset Management Co., Ltd.as of 09 Jan 2026223.00k0.73%
Daiwa Asset Management Co. Ltd.as of 30 Dec 2025213.70k0.70%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 202698.80k0.32%
BlackRock Japan Co. Ltd.as of 08 Jan 202642.50k0.14%
Asset Management One Co., Ltd.as of 08 Jan 202624.10k0.08%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 08 Jan 202622.80k0.08%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Sep 202522.00k0.07%
Fidelity Investments Canada ULCas of 30 Nov 202519.10k0.06%
More ▼
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.